Results 21 to 30 of about 34,447 (277)

Hyperandrogenism syndrome: diagnostics and treatment from the position of clinical endocrinology

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2020
Hyperandrogenism, a pathological condition caused by the effect of excess production of androgens on target organs and tissues, is one of the most common hormonal disorders observed in 5–20 % of women of reproductive age in the population and in 35–41 ...
M.R. Mykytyuk, O.O. Khyzhnyak
doaj   +1 more source

Adrenal Hyperandrogenism in Children [PDF]

open access: yesThe Journal of Clinical Endocrinology & Metabolism, 1999
H of a mild-to-moderate degree is probably the most common abnormality in normoestrogenic menstrual disturbances. Androgen excess arises from abnormal ovarian or adrenal sources. The adrenal androgens, normally secreted by the fetal adrenal zone or the zona reticularis, are steroid hormones with weak androgen activity. Although adrenal androgens do not
GHIZZONI, Lucia   +2 more
openaire   +4 more sources

The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report

open access: yesMetabolites, 2022
Leydig cell tumors (LCTs) refer to tumors of the stroma of the genital strand, which are found mainly in postmenopausal women. The diagnosis of LCTs in postmenopausal women is associated with specific difficulties and is based on the identification of ...
Larisa V. Suturina   +6 more
doaj   +1 more source

Salivary testosterone measurement in women with and without polycystic ovary syndrome [PDF]

open access: yes, 2017
Clinical and/or biochemical hyperandrogenism is one of the diagnostic criteria for PCOS. An evaluation of the role of salivary testosterone (salT) and androstenedione (salA) for the diagnosis of PCOS was undertaken in a cross sectional study involving 65
Adaway, Joanne   +9 more
core   +1 more source

High levels of follicular fluid testosterone could impair oocyte developmental competency via affecting aryl hydrocarbon receptor pathway in PCOS patients

open access: yesBMC Molecular and Cell Biology, 2022
Background Although hormonal and metabolic dysfunction have been recognized as a possible cause of polycystic ovarian syndrome (PCOS), the associations between hyperandrogenism and aryl hydrocarbon receptor (Ahr) signaling pathway remains controversial ...
Fatemeh Eini   +3 more
doaj   +1 more source

Hyperandrogenism and insulin resistance modulate gravid uterine and placental ferroptosis in PCOS-like rats.

open access: yesJournal of Endocrinology, 2020
Previous studies in rats showed that maternal exposure to 5α-dihydrotestosterone (DHT) and insulin (INS) from gestational day 7.5 to 13.5 induces hyperandrogenism and insulin resistance (HAIR) and subsequently leads to placental insufficiency and fetal ...
Yuehui Zhang   +16 more
semanticscholar   +1 more source

DIAGNOSIS OF HYPERANDROGENISM: DIFFICULTY AND THE CONSEQUENCES

open access: yesМедицинский вестник Юга России, 2017
Objective: to evaluate the prescription of drug treatment of hyperandrogenism according to the diagnostic algorithm by endocrinologists in clinical practice.Materials and methods: retrospective analysis of 15 case reports of women with established ...
N. I. Volkova   +3 more
doaj   +1 more source

Letrozole treatment of pubertal female mice results in activational effects on reproduction, metabolism and the gut microbiome. [PDF]

open access: yes, 2019
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in reproductive-aged women that is comprised of two out of the following three features: hyperandrogenism, oligo- or amenorrhea, or polycystic ovaries. In addition to infertility, many women
Arroyo, Pablo   +4 more
core   +2 more sources

Bloodletting has no effect on the blood pressure abnormalities of hyperandrogenic women taking oral contraceptives in a randomized clinical trial

open access: yesScientific Reports, 2021
Normoferritinemic women with functional hyperandrogenism show a mild iron overload. Iron excess, hyperandrogenism, and cardioautonomic dysfunction contribute to blood pressure (BP) abnormalities in these patients.
Manuel Luque-Ramírez   +9 more
doaj   +1 more source

Variations of Steroid Hormone Metabolites in Serum and Urine in Polycystic Ovary Syndrome after Nafarelin Stimulation: Evidence for an Altered Corticoid Excretion. [PDF]

open access: yes, 1995
To evaluate the clinical relevance of testing pituitary-ovarian responses in patients suffering from polycystic ovary syndrome (PCOS) with the GnRH agonist nafarelin, a 1.2-mg dose of nafarelin was given intranasally to 19 women with PCOS and 15 healthy ...
A. Lob   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy